Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women.
BACKGROUND
The BRCA1 gene is an important breast-cancer susceptibility gene. Promoter polymorphisms can alter the binding affinity of transcription factors, changing transcriptional activity and may affect susceptibility to disease.


RESULTS
Using direct sequencing of the BRCA1 promoter region, we identified four polymorphisms c.-2804T-->C (rs799908:T-->C), c.-2265C-->T (rs11655505:C-->T), c.-2004A-->G (rs799906:A-->G) and c.-1896(ACA)(1)-->(ACA)(2) (rs8176071:(ACA)(1)-->(ACA)(2)) present in Hong Kong Chinese. Each polymorphism was studied independently and in combination by functional assays. Although all four variants significantly altered promoter activity, the c.-2265T allele had stronger binding than the C allele, and the most common mutant haplotype, which contains the c.-2265T allele, increased promoter activity by 70%. Risk association first tested in Hong Kong Chinese women with breast cancer and age-matched controls and replicated in a large population-based study of Shanghai Chinese, together totalling >3000 participants, showed that carriers of the c.-2265T allele had a reduced risk for breast cancer (combined odd ratio (OR) = 0.80, 95% CI 0.69 to 0.93; p = 0.003) which was more evident among women aged >or=45 years at first diagnosis of breast cancer and without a family history of breast cancer (combined OR = 0.75, 95% CI 0.61 to 0.91; p = 0.004). The most common haplotype containing the c.-2265T allele also showed significant risk association for women aged >or=45 years without a family history of breast cancer (OR = 0.64, 95% CI 0.46 to 0.89; p = 0.008).


CONCLUSIONS
This comprehensive study of BRCA1 promoter polymorphisms found four variants that altered promoter activity and with the most significant contribution from c.-2265C-->T, which could affect susceptibility to breast cancer in the Chinese population. Its significance in other populations remains to be investigated.
Chan
K Y-K
KY
Department of Pathology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.
Liu
W
W
Long
J-R
JR
Yip
S-P
SP
Chan
S-Y
SY
Shu
X-O
XO
Chua
D T-T
DT
Cheung
A N-Y
AN
Ching
J C-Y
JC
Cai
H
H
Au
G K-H
GK
Chan
M
M
Foo
W
W
Ngan
H Y-S
HY
Gao
Y-T
YT
Ngan
E S-W
ES
Garcia-Barceló
M-M
MM
Zheng
Wei
W
Khoo
U-S
US
D044466:Asian People / Q000235:genetics; D019313:BRCA1 Protein / Q000235:genetics*; D001665:Binding Sites; D001943:Breast Neoplasms / Q000453:epidemiology / Q000235:genetics*; D016022:Case-Control Studies; D002681:China / Q000453:epidemiology; D015331:Cohort Studies; D024202:Electrophoretic Mobility Shift Assay; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006723:Hong Kong / Q000453:epidemiology; D006801:Humans; D011110:Polymorphism, Genetic / Q000235:genetics*; D011401:Promoter Regions, Genetic / Q000235:genetics*; D012307:Risk Factors; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism; D014158:Transcription, Genetic
D019313:BRCA1 Protein; C492913:BRCA1 protein, human; D014157:Transcription Factors
J Biol Chem. 1999 Mar 26;274(13):8837-43
10085126
Breast Cancer Res Treat. 2005 May;91(2):179-86
15868446
Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8638-43
11438703
Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1290-5
15298948
Clin Chem. 2003 Oct;49(10):1656-9
14500591
Hum Mol Genet. 1997 Feb;6(2):285-9
9063749
Carcinogenesis. 2000 Sep;21(9):1761-5
10964110
Int J Cancer. 1998 Jul 3;77(1):1-6
9639385
Am J Hum Genet. 2007 Sep;81(3):559-75
17701901
Nucleic Acids Res. 1998 Jan 1;26(1):362-7
9399875
Cancer Res. 2004 Oct 15;64(20):7622-8
15492291
Hum Mol Genet. 1995 Dec;4(12):2259-64
8634696
Cancer Res. 2003 Sep 15;63(18):5727-30
14522892
N Engl J Med. 1997 May 15;336(20):1409-15
9145677
Nat Rev Cancer. 2007 Dec;7(12):937-48
18034184
Hum Mol Genet. 2005 Jan 15;14(2):191-204
15548547
Oncogene. 1999 Aug 12;18(32):4643-6
10467410
Breast Cancer Res. 2005;7(2):R171-5
15743496
J Biol Chem. 1997 Aug 22;272(34):20994-7
9261099
Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1148-52
16775174
Int J Cancer. 2000 Jul 15;87(2):295-300
10861490
Breast Cancer Res Treat. 2007 Nov;106(1):121-6
17431766
J Natl Cancer Inst. 2001 Aug 15;93(16):1215-23
11504767
Bioinformatics. 2005 Jan 15;21(2):263-5
15297300
Nucleic Acids Res. 2000 Sep 1;28(17):3233-9
10954590
Nat Genet. 1995 Apr;9(4):444-50
7795653
Cancer Res. 2005 Aug 15;65(16):7516-22
16103107
Cancer Res. 2002 Jul 15;62(14):4151-6
12124354
Science. 2003 Oct 24;302(5645):643-6
14576434
Am J Hum Genet. 1998 Mar;62(3):676-89
9497246